uniQure N.V. (0EE0.L)

USD 8.8

(-3.27%)

Inventory Summary of uniQure N.V.

  • uniQure N.V.'s latest annual inventory in 2023 was 12.02 Million USD , up 73.66% from previous year.
  • uniQure N.V.'s latest quarterly inventory in 2024 Q1 was 7.67 Million USD , down -36.19% from previous quarter.
  • uniQure N.V. reported annual inventory of 6.92 Million USD in 2022, down -34.31% from previous year.
  • uniQure N.V. reported annual inventory of 10.54 Million USD in 2021, up 143.03% from previous year.
  • uniQure N.V. reported quarterly inventory of - USD for 2024 Q2, down -100.0% from previous quarter.
  • uniQure N.V. reported quarterly inventory of 7.67 Million USD for 2024 Q1, down -36.19% from previous quarter.

Annual Inventory Chart of uniQure N.V. (2023 - 2010)

Historical Annual Inventory of uniQure N.V. (2023 - 2010)

Year Inventory Inventory Growth
2023 12.02 Million USD 73.66%
2022 6.92 Million USD -34.31%
2021 10.54 Million USD 143.03%
2020 4.33 Million USD -8.08%
2019 4.71 Million USD 322.76%
2018 1.11 Million USD -2.02%
2017 1.13 Million USD 14.36%
2016 996 Thousand USD 109.43%
2015 475.58 Thousand USD 95.55%
2014 243.2 Thousand USD -79.64%
2013 1.19 Million USD 207.72%
2012 -1.1 Million USD 0.0%
2011 - USD -100.0%
2010 1.00 USD 0.0%

Peer Inventory Comparison of uniQure N.V.

Name Inventory Inventory Difference
Agios Pharmaceuticals, Inc. 19.07 Million USD 36.968%
Amicus Therapeutics, Inc. 59.69 Million USD 79.858%
Atara Biotherapeutics, Inc. 9.7 Million USD -23.882%
bluebird bio, Inc. 22.91 Million USD 47.537%
Cara Therapeutics, Inc. 2.82 Million USD -326.232%
Imunon, Inc. - USD -Infinity%
Editas Medicine, Inc. - USD -Infinity%
IQVIA Holdings Inc. - USD -Infinity%
Mettler-Toledo International Inc. 385.86 Million USD 96.884%
Myriad Genetics, Inc. 20.1 Million USD 40.179%
Neurocrine Biosciences, Inc. 38.3 Million USD 68.606%
Supernus Pharmaceuticals, Inc. 77.4 Million USD 84.467%
Verastem, Inc. - USD -Infinity%
Walgreens Boots Alliance, Inc. 8.32 Billion USD 99.855%
Waters Corporation 516.23 Million USD 97.671%
Thermo Fisher Scientific Inc. 5.08 Billion USD 99.764%
Biogen Inc. 2.52 Billion USD 99.524%
Nektar Therapeutics 16.1 Million USD 25.321%
Perrigo Company plc 1.14 Billion USD 98.946%
Dynavax Technologies Corporation 53.29 Million USD 77.437%
Illumina, Inc. 587 Million USD 97.952%
Corbus Pharmaceuticals Holdings, Inc. - USD -Infinity%
Iovance Biotherapeutics, Inc. 10.37 Million USD -15.927%
Heron Therapeutics, Inc. 42.11 Million USD 71.446%
Unity Biotechnology, Inc. - USD -Infinity%
BioMarin Pharmaceutical Inc. 1.1 Billion USD 98.914%
Sangamo Therapeutics, Inc. - USD -Infinity%
Evolus, Inc. 10.99 Million USD -9.329%
Adicet Bio, Inc. - USD -Infinity%
Aclaris Therapeutics, Inc. - USD -Infinity%
Regeneron Pharmaceuticals, Inc. 2.58 Billion USD 99.534%
Esperion Therapeutics, Inc. 65.62 Million USD 81.677%
FibroGen, Inc. 41.56 Million USD 71.072%
Agilent Technologies, Inc. 1.03 Billion USD 98.834%
OPKO Health, Inc. 65.69 Million USD 81.698%
Homology Medicines, Inc. - USD -Infinity%
Geron Corporation - USD -Infinity%
Alnylam Pharmaceuticals, Inc. 89.14 Million USD 86.512%
Exelixis, Inc. 17.32 Million USD 30.589%
Viking Therapeutics, Inc. - USD -Infinity%
Anavex Life Sciences Corp. - USD -Infinity%
Intellia Therapeutics, Inc. - USD -Infinity%
Zoetis Inc. 2.56 Billion USD 99.531%
Axsome Therapeutics, Inc. 15.13 Million USD 20.555%
Abeona Therapeutics Inc. -2.44 Million USD 591.98%
Vertex Pharmaceuticals Incorporated 738.8 Million USD 98.372%
Kala Pharmaceuticals, Inc. - USD -Infinity%
Ionis Pharmaceuticals, Inc. 28.42 Million USD 57.699%
Sarepta Therapeutics, Inc. 322.85 Million USD 96.276%
Corcept Therapeutics Incorporated 7.73 Million USD -55.55%
Halozyme Therapeutics, Inc. 127.6 Million USD 90.577%
Blueprint Medicines Corporation 21.22 Million USD 43.344%
Insmed Incorporated 83.24 Million USD 85.556%
TG Therapeutics, Inc. 39.82 Million USD 69.806%
Incyte Corporation 62.97 Million USD 80.906%
Emergent BioSolutions Inc. 328.9 Million USD 96.344%